Point72 Asset
View Older Stories View More Recent Stories
-
Encompass Health appoints Kevin O'Connor to its Board of Directors
-
PREIT Endorses Shareholder Nominations for Two New Independent Trustees as Representatives for Preferred Shareholders
-
Cohen Veterans Network Launches New Research Institute to Improve Mental Health Outcomes for Veterans, Service Members and Their Families
-
R-Three Technologies, Inc. Appoints Three New Board Members; Steve Cohen, Marcia Dyson and Aaron Anderson Join Board of Publicly Traded Company, Effective Immediately
-
R-Three Technologies, Inc. Appoints Three New Board Members; Steve Cohen, Marcia Dyson and Aaron Anderson Join Board of Publicly Traded Company, Effective Immediately
-
R-Three Technologies, Inc. Appoints Three New Board Members; Steve Cohen, Marcia Dyson and Aaron Anderson Join Board of Publicly Traded Company, Effective Immediately
-
R-Three Technologies, Inc. Appoints Three New Board Members; Steve Cohen, Marcia Dyson and Aaron Anderson Join Board of Publicly Traded Company, Effective Immediately
-
Easterseals DC MD VA and Octo Partner to Enhance Learning from Program Data, Support for Veterans and Children
-
New York Mortgage Trust (NYMT) Announces Strategic Investment From New York Mortgage Trust
-
AlphaFlow Announces Strategic Investment From New York Mortgage Trust
-
Steve Cohen’s Point72 to redeem $750 million from Melvin Capital - Bloomberg News
-
Investment Management and Technology Veterans Launch Non-Profit Foundation to Develop Regulated DeFi Asset Management Platform
-
Certa Raises $15M Series A to Eliminate the Enterprise Procurement Bottleneck
-
Hope Solo to Launch New SiriusXM Podcast - Hope Solo Speaks
-
CYGNUS CAPITAL, INC. ISSUES OPEN LETTER TO SHAREHOLDERS OF PENNSYLVANIA REAL ESTATE INVESTMENT TRUST
-
Form SC 13G IDEAYA Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
FRESH START SURGICAL GIFTS SURPASSES $50 MILLION IN DONATED MEDICAL CARE OFFERING LIFE-CHANGING SURGERIES TO CHILDREN IN NEED THROUGHOUT THE US
-
Form SC 13G/A Paya Holdings Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A BELLUS Health Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A BLUE OWL CAPITAL INC. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Kindred Biosciences, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Theravance Biopharma, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form 13F-HR Point72 Asset Management For: Dec 31
-
Form SC 13G/A Mereo Biopharma Group Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A F-star Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Oyster Point Pharma, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A CHIMERIX INC Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Krystal Biotech, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Cepton, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Kadmon Holdings, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Global Blood Therapeutic Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Tricida, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A CURIS INC Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Regulus Therapeutics Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Bakkt Holdings, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Atara Biotherapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G Revolve Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Poshmark, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A ANAPTYSBIO, INC Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Xenon Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A BLUE OWL CAPITAL INC. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Prometheus Biosciences, Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Affimed N.V. Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Protagonist Therapeutics Filed by: Point72 Asset Management, L.P.
-
Form SC 13G/A Allena Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
